Identification of Compounds That Promote Readthrough of Premature Termination Codons in the CFTR.


Journal

SLAS discovery : advancing life sciences R & D
ISSN: 2472-5560
Titre abrégé: SLAS Discov
Pays: United States
ID NLM: 101697563

Informations de publication

Date de publication:
Feb 2021
Historique:
pubmed: 6 10 2020
medline: 19 2 2022
entrez: 5 10 2020
Statut: ppublish

Résumé

Cystic fibrosis (CF) is caused by a mutation of the Cystic Fibrosis Transmembrane Conductance Regulator (

Identifiants

pubmed: 33016182
doi: 10.1177/2472555220962001
pmc: PMC7838340
pii: S2472-5552(22)06672-2
doi:

Substances chimiques

CFTR protein, human 0
Codon, Nonsense 0
Small Molecule Libraries 0
Cystic Fibrosis Transmembrane Conductance Regulator 126880-72-6

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

205-215

Subventions

Organisme : NIH HHS
ID : S10 OD025279
Pays : United States
Organisme : NIH HHS
ID : S10 OD025282
Pays : United States
Organisme : NIH HHS
ID : S10 OD026857
Pays : United States

Références

J Med Chem. 2010 Apr 8;53(7):2719-40
pubmed: 20131845
Biomed Res Int. 2016;2016:5258727
pubmed: 27340661
Eur J Hum Genet. 2014 Jun;22(6):784-91
pubmed: 24129438
RNA. 2000 Jul;6(7):1044-55
pubmed: 10917599
Drug Discov Today. 2003 Dec 15;8(24):1128-37
pubmed: 14678739
J Biomol Screen. 2013 Sep;18(8):930-7
pubmed: 23640875
J Am Chem Soc. 2002 Feb 27;124(8):1594-6
pubmed: 11853431
J Cyst Fibros. 2020 Sep;19(5):733-741
pubmed: 32067958
Drug Discov Today. 2003 Oct 1;8(19):876-7
pubmed: 14554012
Proc Natl Acad Sci U S A. 2011 Nov 15;108(46):18843-8
pubmed: 21976485
Nature. 2006 Mar 23;440(7083):477-83
pubmed: 16554808
Assay Drug Dev Technol. 2010 Dec;8(6):669-84
pubmed: 21050065
J Cyst Fibros. 2014 Jul;13(4):403-9
pubmed: 24440181
Hum Mol Genet. 1992 Oct;1(7):542-4
pubmed: 1284888
J Biomol Screen. 1999;4(2):67-73
pubmed: 10838414
SLAS Discov. 2018 Feb;23(2):111-121
pubmed: 28898585
Proc Natl Acad Sci U S A. 2009 Nov 3;106(44):18825-30
pubmed: 19846789
Hum Mol Genet. 2017 Aug 15;26(16):3116-3129
pubmed: 28575328
Mol Biol Cell. 2016 Feb 1;27(3):424-33
pubmed: 26823392
Adv Drug Deliv Rev. 2001 Mar 1;46(1-3):3-26
pubmed: 11259830
J Med Chem. 2009 Nov 12;52(21):6752-6
pubmed: 19827778
Assay Drug Dev Technol. 2017 Dec;15(8):395-406
pubmed: 29172645
J Med Genet. 1992 Feb;29(2):131-3
pubmed: 1377276

Auteurs

Emery Smith (E)

Department of Molecular Medicine, Scripps Florida, The Scripps Research Institute Molecular Screening Center, Jupiter, FL, USA.

Danijela Dukovski (D)

Proteostasis Therapeutics, Inc., Boston, MA, USA.

Justin Shumate (J)

Department of Molecular Medicine, Scripps Florida, The Scripps Research Institute Molecular Screening Center, Jupiter, FL, USA.

Louis Scampavia (L)

Department of Molecular Medicine, Scripps Florida, The Scripps Research Institute Molecular Screening Center, Jupiter, FL, USA.

John P Miller (JP)

Proteostasis Therapeutics, Inc., Boston, MA, USA.

Timothy P Spicer (TP)

Department of Molecular Medicine, Scripps Florida, The Scripps Research Institute Molecular Screening Center, Jupiter, FL, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH